CDRD, Canada’s national drug development and commercialization engine, is hosting a symposium “Immunotherapy: Novel platforms and strategies advancing cancer research.”
Join us and top oncology researchers from across Canada to learn about recent advances in immunotherapy, outcomes, lessons learned and where we are headed.
The full day session includes short and concise talks, a moderated panel discussion, brainstorming sessions and opportunities to networks and explore potential partnerships and collaborations.
This event is free of charge but pre-registration is required: https://cdrd-immunotherapy.eventbrite.ca.
8:30 – 8:50am: Continental breakfast
8:45 – 9:00am: Welcoming remarks and brief overview of CDRD’s Immunotherapy Initiative
9:00 – 9:40am: “The power of the fish for immunotherapy research” – Dr. Jason Berman (MSC Clinician Scientist in Pediatric Oncology, IWK Health Centre)
9:40 – 10:00am: Dr. Brad Nelson (Director and Distinguished Scientist, Deeley Research Centre, BC Cancer Agency)
10:00 – 10:20am: Dr. Rebecca Auer (Scientist, Cancer Therapeutics Program, Ottawa Hospital Research Institute)
10:20 – 10:50am: Coffee break and networking
10:50 – 11:10am: Dr. Carl Hansen (CEO & President, Co-Founder, AbCellera)
11:10 – 11:30am: Dr. Rob Holt (Head of Sequencing, Michael Smith Genome Sciences Centre, and Distinguished Scientist, BC Cancer Agency)
11:30 – 11:50am: Dr. Thomas Kislinger (Senior Scientist, Princess Margaret Cancer Centre)
11:50am – 12:50pm: Moderated Panel Discussion, Q&A session
12:50 – 1:50pm: Networking lunch